key: cord-0711351-8c6m6rc4
authors: Guzman, Nelson Alvis; De la Hoz Restrepo, Fernando; Serrano-Coll, Hector; Gastelbondo, Bertha; Mattar, Salim
title: Using serological studies to assess COVID-19 infection fatality rate in developing countries. A case study from one Colombian department
date: 2021-06-11
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.06.018
sha: 2bb453e1712f05e1d0b0a43e7b7e4e31dbfdffe5
doc_id: 711351
cord_uid: 8c6m6rc4

nan

Developing countries; health care effectiveness.

The infection fatality rate (IFR) is a critical epidemiological parameter that allows assessment of any infectious agent's dynamics and virulence and the quality of health services. (1) There is still uncertainty about the true IFR of COVID-19 because detecting all infections and cases depends on the quality of surveillance and the number of tests available. Attempting to estimate IFR in developing countries is incredibly challenging, since they have weaker surveillance systems coupled with a deficit of laboratories able to carry out molecular tests across the entire territory.

There have been attempts to estimate IFR using serological estimates, but there are few serological studies from developing countries. In systematic reviews conducted by Ioannidis J and Levin A et al., only 6 developing countries had IFR estimates. (1, 2) J o u r n a l P r e -p r o o f By March 5 th 2021, Colombia has been hit by two waves of COVID-19, reporting 2,2 million cases and 60,300 deaths (Case Fatality Rate, CFR=2.6%) (3) . However, the real number of infected people is unknown because of geographical differences in the surveillance systems' performance and laboratory capacities across different country's areas. Thus, Colombia lacks accurate estimates on IFR (4). So far, only 3 Latin American countries -Argentina, Brazil and Chile-has informed IFR from serological surveys. (2) . In this short report, we attempt to fill that gap by estimating IFR from a population-based serological survey in one department of Colombia, Cordoba (Population=1,785,000), which was carried out during the aftermath of the first peak the pandemic (August-September 2020).

Methods to select participants and characteristics of serological tests used have been described elsewhere. (5) . Briefly, 2,447 people, above 9 years old, were selected from randomly selected households from all neighborhoods in 6 cities of the department. Blood samples were taken after a consent format was signed, and sera were collected from native individuals from the Córdoba Department. Sera were tested at the Instituto de Investigaciones Biológicas del Trópico using INgezim COVID 19 DR test (Ingenasa, Eurofins Madrid, Spain), a dual recognition ELISA, detecting semi-quantitatively total SARS-CoV-2 virus N-protein-specific antibodies (IgG, IgM, and IgA). It has a sensitivity (Se) of 93% and a specificity (Sp) of 95%. Prevalence data was adjusted by Se and Sp.

All Covid-19 deaths detected in the cities of the study between March 2020 and October 9th, 2020 (one week after the serological study) were included in the analysis. Deaths, seropositive people, detected Covid-19 cases, and population size were disaggregated by the age groups showed in Table 1 . The number of people infected was estimated by specific age groups, along with the 95% Confidence intervals (95% CI), by multiplying the proportion of seropositive by J o u r n a l P r e -p r o o f the population size of the same group. Then, COVID-19 deaths (confirmed by PCR or antigen tests) were divided by the size of the population infected to obtain IFR by age group. CFR by age group was estimated dividing deaths by the number of cases detected by the surveillance system. Table 1 .

There were 1,618 Covid-19 deaths during the study period for a CFR of 5.6%, an IFR of 0.24% (for people aged 10 yrs and older) and a mortality rate of 104 per 10 5 . All estimators were lower among young people and increase substantially among the oldest age groups. The lowest IFR value was observed for people 10-14 years, 0.001%, and the highest value among people 70 years old or older, 1.5%. The overall ratio CFR:IFR was 23 but it was wider among the youngest people -100 for children under 15 years old-decreasing to 25 for the age group between 20 to 29 years old and leveling afterwards between 17 and 21. This is the first report in Colombia attempting to estimate IFR from a serological survey. It shows two important things: First, that CFR overestimate the lethality of COVID-19 and second, that the bias is differential by age groups. IFR is lower than CFR for every age group but especially for those under 25 years old. The surveillance system identified one in every 22 infected cases, but only one in 100 for children under 15 years old. The IFR obtained in this study rise the issue about the utility of CFR to assess the effectiveness of health services. By the time of the survey, Cordoba had twice the CFR of the country, 3.1%, but a sizable portion of the difference is explained by surveillance sensitivity and not by health care effectiveness.

One potential source of error of our study is that serological tests do not have 100% of Se and Sp which may overestimate the IFR. However, we adjusted the prevalence by Se and Sp and there was no important differences between adjusted and unadjusted values. Therefore, these results J o u r n a l P r e -p r o o f may guide the discussion about the right control measures that should be adopted to control future epidemic waves. (6) Founding source: This work was partially supported by a grant from the Ministerio de Ciencia Tecnología e Innovación, Colombia (MINCIENCIAS). Research project: "Fortalecimiento de capacidades instaladas de ciencia y tecnología de la Universidad de Córdoba para atender problemáticas asociadas con agentes biológicos de alto riesgo para la salud humana en el departamento de Córdoba".

Ethical approval: The study protocol was approved by the research committee of the Institute of Tropical Biological Research of the University of Cordoba. Informed consent was obtained from all participants.

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 104.0 (100.0-109.0) *Expected infections= (seropositivity*Population 2020)/100. ** population under 10 years old was excluded from the serological survey and consequently from these estimates.

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

Infection fatality rate of COVID-19 inferred from seroprevalence data

Bull World Health Organ

Evaluación comparativa de la vigilancia en salud pública de COVID-19 en Colombia: Primer semestre

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries? Open Forum Infect Dis